Jeff Hutchins

Jeff Hutchins

Plus aucun poste en cours
67 ans
Health Technology
Consumer Services

Profil

Jeff T.
Hutchins
worked as a Director of Monoclonal Antibody Development at Glaxo Wellcome, Inc. from 1991 to 2007.
He then worked as a Vice President of Preclinical Research at Avid Bioservices, Inc. from 2012 to 2016.
He also held the position of Vice President of Preclinical Development at Inhibitex LLC.
Later, he worked as the Chief Operating & Scientific Officer at Scorpius Holdings, Inc. from 2017 to 2020.
He also worked as a Senior Vice President at Pelican Therapeutics, Inc. Dr. Hutchins received his undergraduate degree from Oral Roberts University and his doctorate from The University of Texas Health Science Center at Houston.

Anciens postes connus de Jeff Hutchins

SociétésPosteFin
SCORPIUS HOLDINGS, INC. Directeur des opérations 31/12/2020
AVID BIOSERVICES, INC. Corporate Officer/Principal 01/12/2016
Corporate Officer/Principal 01/01/2007
Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de Jeff Hutchins

Formation de Jeff Hutchins

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

33

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

  1. Bourse
  2. Insiders
  3. Jeff Hutchins
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT